A clinicopathological study of early-stage synchronous bilateral breast cancer: a retrospective evaluation and prospective validation of potential risk factors
- PMID: 24736632
- PMCID: PMC3988153
- DOI: 10.1371/journal.pone.0095185
A clinicopathological study of early-stage synchronous bilateral breast cancer: a retrospective evaluation and prospective validation of potential risk factors
Abstract
Background: The aim of the present study was to investigate potential risk factors for synchronous bilateral breast cancer sBBC).
Methods: A retrospective analysis was performed of patients diagnosed and treated with operable bilateral breast cancer (BBC) between June 2007 and December 2011. Risk factors for sBBC were evaluated in this cohort and further validated in a prospective observational validation analysis of patients between January 2012 and December 2012. Patients treated with operable unilateral breast cancer during the same period were used as a control group.
Results: A total of 11,247 patients with primary breast cancer underwent operations at the Fudan University Shanghai Cancer Center between June 2007 and December 2012. The incidence of sBBC was 1.6%. The age at diagnosis (HR = 2.4, 95% C.I.: 1.4-4.0, p = 0.001), presence of sclerosing adenosis (HR = 11.8, 95% C.I.: 5.3-26.3, p<0.001), lobular carcinoma component involvement (HR = 5.6, 95% C.I.: 2.6-12.1, p<0.001), and family history of first-degree relatives with breast cancer (HR = 2.0, 95% C.I.: 1.1-3.4, p<0.001) were independent risk factors for sBBC. A subsequent validation study failed to confirm the significance of family history. No significant difference on survival was found between patients with early-stage sBBC and control cases.
Conclusions: Patients with the presence of sclerosing in the affected breast, and lobular carcinoma component involvement may be at high risk for developing sBBC. This study supports the hypothesis that the host-carcinoma biological relationship, especially for the tumor microenvironment, played a critical role in the carcinogenesis of sBBC.
Conflict of interest statement
Figures


Similar articles
-
Surgical management for early-stage bilateral breast cancer patients in China.PLoS One. 2015 Apr 13;10(4):e0122692. doi: 10.1371/journal.pone.0122692. eCollection 2015. PLoS One. 2015. PMID: 25874699 Free PMC article.
-
Bilateral breast cancer in China: A 10-year single-center retrospective study (2006-2016).Cancer Med. 2021 Sep;10(17):6089-6098. doi: 10.1002/cam4.4141. Epub 2021 Aug 4. Cancer Med. 2021. PMID: 34346560 Free PMC article.
-
Synchronous bilateral breast cancer: a nationwide study on histopathology and etiology.Breast Cancer Res Treat. 2020 Jul;182(1):229-238. doi: 10.1007/s10549-020-05689-0. Epub 2020 May 21. Breast Cancer Res Treat. 2020. PMID: 32441019
-
Bilateral Breast Cancer.Am Surg. 2025 May;91(5):854-858. doi: 10.1177/00031348251323713. Epub 2025 Feb 21. Am Surg. 2025. PMID: 39982251 Review.
-
Prognosis of synchronous bilateral breast cancer: a review and meta-analysis of observational studies.Breast Cancer Res Treat. 2014 Aug;146(3):461-75. doi: 10.1007/s10549-014-3045-0. Epub 2014 Jul 10. Breast Cancer Res Treat. 2014. PMID: 25007962 Review.
Cited by
-
Estrogen Receptor Expression Is Associated with DNA Repair Capacity in Breast Cancer.PLoS One. 2016 Mar 31;11(3):e0152422. doi: 10.1371/journal.pone.0152422. eCollection 2016. PLoS One. 2016. PMID: 27032101 Free PMC article.
-
Sclerosing adenosis as a predictor of breast cancer bilaterality and multicentricity.Virchows Arch. 2015 Jul;467(1):71-8. doi: 10.1007/s00428-015-1769-9. Epub 2015 Apr 3. Virchows Arch. 2015. PMID: 25838080
-
A comparative clinicopathological and survival analysis of synchronous bilateral breast cancers.Histol Histopathol. 2022 Aug;37(8):791-802. doi: 10.14670/HH-18-449. Epub 2022 Mar 14. Histol Histopathol. 2022. PMID: 35285011
-
Advanced lesions of synchronous bilateral mammary Paget's disease: a case report.J Med Case Rep. 2020 Aug 4;14(1):119. doi: 10.1186/s13256-020-02442-5. J Med Case Rep. 2020. PMID: 32753069 Free PMC article.
-
Synchronous bilateral breast cancer patients submitted to conservative treatment and brachytherapy - The experience of a service.Rep Pract Oncol Radiother. 2018 Sep-Oct;23(5):322-330. doi: 10.1016/j.rpor.2018.06.004. Epub 2018 Aug 13. Rep Pract Oncol Radiother. 2018. PMID: 30127671 Free PMC article. Review.
References
-
- Kilgore AR (1921) The incidence of cancer in the second breast: after radical removal of one breast for cancer. JAMA : the journal of the American Medical Association. 77(6): 454–7.
-
- Abdalla I, Thisted RA, Heimann R (2006) The impact of contralateral breast cancer on the outcome of breast cancer patients treated by mastectomy. Cancer journal. 6(4): 266–72. - PubMed
-
- Bloom ND, Daluvoy RV, Ceccarelli F, Degenshein GA (1980) Bilateral mammary carcinoma; immunologic implications. New York state journal of medicine. 80(6): 908–10. - PubMed
-
- Hartman M, Czene K, Reilly M, Bergh J, Lagiou P, et al. (2005) Genetic implications of bilateral breast cancer: a population based cohort study. The lancet oncology. 6(6): 377–82. - PubMed
-
- Schmid SM, Pfefferkorn C, Myrick ME, Viehl CT, Obermann E, et al. (2011) Prognosis of early-stage synchronous bilateral invasive breast cancer. European journal of surgical oncology : the journal of the European Society of Surgical Oncology and the British Association of Surgical Oncology. 37(7): 623–8. - PubMed
Publication types
MeSH terms
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical